Zhonghua Xiong

Dr. Zhonghua Xiong

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2025 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
ZXZhonghua Xiong
Zhonghua Xiong
JZJing Zhang
Jing Zhang
QDQinqin Deng
Qinqin Deng
MWMinghui Wang
Minghui Wang
TLTianfu Li
Tianfu Li
Introduction: Vagus nerve stimulation (VNS) represents a clinically approved neuromodulatory intervention for managing refractory epilepsy. VNS exhibits antiepileptogenic effects in animal models; the molecular and cellular mechanisms driving these effects have yet to be fully elucidated. Epigenetic alterations, including DNA and RNA methylation, are implicated in the pathogenesis of epilepsy. This study was designed to examine whether VNS inhibits DNA/RNA methylation in temporal lobe epilepsy.Methods: A rat model of temporal lobe epilepsy induced by intraperitoneal injection of lithium chloride‐pilocarpine was used. Naïve control group, Pilo groups (8 and 12 weeks after pilocarpine respectively), VNS group (VNS stimulation for 4w and 8w respectively), and Sham group (VNS off control group, with VNS implanted but not turned on for 4w and 8w respectively). The rats were monitored by video‐EEG. DNMT1 (DNA methyltransferase‐1), DNMT3A (methyltransferase‐3A), 5‐hmC (5‐hydroxymethyl‐cytosine), 5‐mC (5‐methyl‐cytosine), METTL3 (RNA methyltransferase like 3), METTL14 (RNA methyltransferase like 14) were quantified via immunohistochemistry and Western blot.Results: Pilocarpine‐induced epileptic animals were characterized by overexpression of 5‐mC, DNMT1, DNMT3A, METTL3, and METTL14, and a decrease of 5‐hmC. Compared to the Pilo group, VNS significantly inhibited the overexpression of 5‐mC, DNMT1, DNMT3A, METTL3, and METTL14, reduced the downregulation of 5‐hmC, and attenuated spontaneous recurrent seizures (SRSs).Conclusions: We conclude that VNS reduces the number of SRSs in a rat model of epilepsy, concurrently reducing the expression of 5‐mC, DNMT1, DNMT3A, METTL3, and METTL14, as well as the increase of 5‐hmC. These findings suggest that epigenetic modifications, specifically the suppression of DNA and RNA methylation, could constitute a potential target of VNS‐mediated antiepileptic effects.

20 March 2025 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
ZXZhonghua Xiong
Zhonghua Xiong
ZGZhi Guo
Zhi Guo
LZLei Zhao
Lei Zhao
DQDong Qiu
Dong Qiu
YMYanliang Mei
Yanliang Mei
XYXueying Yu
Xueying Yu
Cluster headache (CH) is a highly disabling primary headache disorder with a complex underlying mechanism. However, there are currently no effective targeted therapeutic drugs available. Existing medications often have limited efficacy and numerous side effects, which frequently fail to meet clinical needs. This study aims to identify potential new therapeutic targets for CH through proteome-wide mendelian randomization (PWMR). We used PWMR to estimate the causal effects of plasma proteins on CH. This analysis integrated plasma protein quantitative trait loci (pQTL) data with genome-wide association study (GWAS) results of CH phenotypes. In addition, we conducted various sensitivity analyses, enrichment analyses, phenome-wide MR assessments, protein–protein interaction network construction, and mediation MR analyses to further validate the drug potential of the identified protein targets. We identified 11 protein targets for CH (p < 2.41 × 10–5), with high-priority candidates exhibiting minimal side effects. Phenome-wide MR revealed novel targets—PXDNL, CCN4, PKD1, LGALS9, and MRC1—that show no significant disease-related adverse effects and interact with established preventive CH drug targets. Notably, PXDNL interacts with both acute and preventive CH drug targets. Furthermore, the causal effect of plasma proteins on CH is partially mediated by cortical surface area, with mediation proportions ranging from 3.2% to 10.0%. We identified a set of potential protein targets for CH, characterized by rare side effects and a strong association with the biological mechanisms underlying the disorder. These findings offer valuable insights for the development of targeted drug therapies in the treatment of CH.

16 October 2025 in Current Neuropharmacology
Verified
Journal Article
Closed access
PDF file
ZXZhonghua Xiong
Zhonghua Xiong
RGRan Gao
Ran Gao
RWRenxi Wang
Renxi Wang
TLTianfu Li
Tianfu Li
Introduction: Epilepsy affects over 70 million individuals globally and remains inadequately managed by current antiepileptic drugs, which often present limited efficacy and adverse effects. This study aims to identify novel, safer, and more effective therapeutic targets for epilepsy using a proteome-wide Mendelian randomization (MR) approach. Methods: Using MR, we evaluated causal relationships between plasma proteins and epilepsy and its subtypes risk, integrating protein quantitative trait loci data with genome-wide association study findings. Further validation included: phenome-wide MR to assess specificity, enrichment analysis for functional insights, mediation MR to explore underlying pathways, and protein-protein interaction (PPI) network construction. Results: We identified 29 plasma proteins with putative causal effects on epilepsy and its subtypes. Through phenome-wide MR, we prioritized 6 candidates for all epilepsy, 1 for focal epilepsy, and 12 for generalized epilepsy, each exhibiting favorable safety profiles. These proteins showed minimal associations with non-epilepsy diseases and functionally interacted with known antiepileptic drug targets. Mediation MR revealed that plasma metabolites accounted for 1.6%-22.3% of the total protein effects on epilepsy risk, highlighting the role of metabolic pathways. Discussion: These findings provide strong evidence for novel protein targets with potential therapeutic relevance, some of which mediate their effects through metabolic processes. The functional overlap with existing drug targets further supports their translational value. Conclusion: This study identifies promising protein targets for epilepsy treatment with high specificity and mechanistic relevance, offering new directions for drug development and precision medicine.

12 November 2025 in Cephalalgia
Verified
Journal Article
Open access
CLCunxin Lin
Cunxin Lin
YLYuanxiang Li
Yuanxiang Li
ZWZhuang Wang
Zhuang Wang
CDChenyang Duan
Chenyang Duan
GLGeyu Liu
Geyu Liu
YWYonggang Wang
Yonggang Wang
Background: Neurovascular coupling (NVC) reflects the interaction between cerebral blood flow (CBF) and functional activity. However, the relationship between NVC and migraine chronification remains unclear. This study investigated the state of NVC in migraine patients and evaluated its potential as an imaging feature for migraine chronification using arterial spin labeling (ASL) combined with resting-state functional magnetic resonance imaging (rs-fMRI). Methods: This was a cross-sectional study. Thirty-nine episodic migraine (EM), 61 chronic migraine (CM) patients (25 with medication overuse headache, MOH) and 42 healthy controls (HCs) were recruited in the same period. Imaging data were acquired using a 3.0 T MRI. Regional homogeneity (ReHo) represented functional activity, whereas CBF was quantified via ASL. Correlation coefficient between CBF and ReHo values of each participant in voxel level represented the whole-brain NVC status, whereas the CBF/ReHo ratio represented regional NVC status. Correlations between NVC metrics and clinical characteristics were analyzed in CM patients. Exploratory mediation analysis was conducted to identify mediators between NVC alterations and the clinical characteristics of CM patients. Finally, receiver operating characteristic (ROC) curve was generated to evaluate the diagnostic performance of NVC metrics for migraine chronification. Results: Compared to HCs, both EM and CM patients presented significantly reduced whole-brain CBF-ReHo coupling. Compared to EM patients, CM patients presented a decreased CBF/ReHo ratio in the right precuneus. Correlation analysis revealed that z value of the CBF/ReHo ratio in the right precuneus was negatively correlated with both HIT-6 score and PHQ-9 score; HIT-6 score was positively correlated with PHQ-9 score in CM group. Exploratory mediation analysis indicated that depression mediated the relationship between abnormal NVC and clinical characteristics in CM patients. Finally, ROC curve indicated that the CBF/ReHo ratio in the right precuneus (AUC = 0.75) exhibited high sensitivity and specificity in distinguishing CM from EM patients. Conclusion: Abnormal NVC in the precuneus was involved in migraine chronification, with depression potentially serving as a mediator in this process. NVC metric may serve as an imaging feature for migraine chronification in the future.

23 January 2026 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
QDQinqin Deng
Qinqin Deng
MWMengyang Wang
Mengyang Wang
GCGuanpeng Chen
Guanpeng Chen
XWXiongfei Wang
Xiongfei Wang
ZYZhaofen Yan
Zhaofen Yan
JWJing Wang
Jing Wang
Objective: This study aimed to systematically map the functional organization of the cingulate gyrus using cortical electrical stimulation (CES) guided by the Brainnetome Atlas. Methods: We retrospectively analyzed CES data from 234 patients with drug‐resistant epilepsy who underwent stereoelectroencephalography (SEEG) implantation in the cingulate cortex. A total of 1141 stimulation sites across seven cingulate subregions (A23d, A24rv, A32p, A23v, A24cd, A23c, A32sg) were examined. Responses were categorized into somatosensory, motor, autonomic, vestibular, visual, emotional, memory, and pain‐related phenomena. Results: Key findings included: (1) Somatosensory responses ( n = 99) were widely distributed, with motor responses localized to middle‐posterior subregions (A23c/A24rv/A24cd); (2) Autonomic ( n = 58) and emotional ( n = 15) responses showed broad distribution, with ventral MCC (A24rv) as an affective hub; (3) Pain responses ( n = 30) involved both anterior (affective) and posterior (spatial) subregions; (4) Memory deficits ( n = 8) specifically localized to posterior cingulate (A23d); (5) Visual ( n = 13) and vestibular ( n = 51) responses clustered in posterior and middle‐posterior regions, respectively. Conclusion: This study provides a systematic functional mapping of the cingulate gyrus using the Brainnetome Atlas, demonstrating its integrated role in diverse neurological functions. The findings advance understanding of cingulate pathophysiology and have implications for surgical planning in epilepsy.

2 April 2026 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
GLGeyu Liu
Geyu Liu
CLCunxin Lin
Cunxin Lin
DQDong Qiu
Dong Qiu
XLXiaoshuang Li
Xiaoshuang Li
ZGZhi Guo
Zhi Guo
YWYonggang Wang
Yonggang Wang
The nucleus accumbens (NAc) plays an important role in the chronic pain process and consists of core and shell subregions with distinct connectivity patter